Attributes | Values |
---|
rdf:type
| |
description
| - assaig clínic (ca)
- clinical trial (en)
- clinical trial (en-ca)
- clinical trial (en-gb)
- clinical trial (en-us)
- ensaio clínico (gl)
- ensayo clínico (es)
- ensayu clínicu (ast)
- essai clinique (fr)
- klinisch onderzoek (nl)
- клінічне випробування (uk)
- կլինիկական փորձարկում (hy)
|
rdfs:label
| - Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction (en)
- Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction (nl)
|
skos:prefLabel
| - Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction (en)
- Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction (nl)
|
name
| - Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction (en)
- Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction (nl)
|
title
| |
title
| - An Open-label, Single Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-914143 in Subject With Normal Renal Function and Subjects With Mild, Moderate, Severe, and End-stage Renal Dysfunction (en)
|
end time
| |
end time
| |
instance of
| |
instance of
| |
start time
| |
start time
| |
country
| |
country
| |
research site
| |
research site
| |
short name
| |
short name
| |
minimum age
| |
minimum age
| |
medical condition
| |
sponsor
| |
medical condition
| |
sponsor
| |
number of participants
| |
number of participants
| |
maximum age
| |
maximum age
| |
study type
| |
study type
| |
ClinicalTrials.gov ID
| |
ClinicalTrials.gov ID
| |
clinical trial phase
| |
clinical trial phase
| |
is about
of | |